supp.fit

Vitamin E: study protocols

119 study groups say how much Vitamin E participants took a day. These are the doses the studies gave. They are not a recommendation.

Vitamin E: what the research found →

Dose per serving from products

15,157 products in our catalogue print how much Vitamin E a serving holds.

Most common: 10 mg to 25 mg, 44% of 15,157 products.

Dose per servingProducts
1 mg or less
580
1 mg to 2.5 mg
297
2.5 mg to 5 mg
1,208
5 mg to 10 mg
2,624
10 mg to 25 mg
6,652
25 mg to 50 mg
1,374
50 mg to 100 mg
989
100 mg to 250 mg
783
over 250 mg
650

Dose per serving from research

66 study groups in 40 studies say how much Vitamin E participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 25 mg to 50 mg, 53% of 66 study groups.

Daily doseStudy groups
2.5 mg or less
2
2.5 mg to 5 mg
2
5 mg to 10 mg
2
10 mg to 25 mg
6
25 mg to 50 mg
35
50 mg to 100 mg
3
100 mg to 250 mg
4
250 mg to 500 mg
8
500 mg to 1 g
4

Commonly used together

61 of 119 study groups took Vitamin E with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Vitamin C
38
Beta-Carotene
32
Zinc
20
Selenium
17
Copper
9
Vitamin A
7
Folic Acid
4
Vitamin B12
4
Iron
3
Omega-3 Fatty Acids
3

119 study groups

Study
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico
1999 · Vitamin E · Patients who survived a recent myocardial infarction (within 3 months); age and sex not specified
300 mg1278 days2,830
Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy
2003 · group one · Patients with cancer receiving cisplatin chemotherapy
300 mg——
Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis
2000 · vitamin E · Smoking and nonsmoking men and postmenopausal women aged 45–69 years with serum cholesterol ≥5.0 mmol/L
182 mg3 years—
Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial
1997 · 200 mg/d vitamin E group · Healthy free-living adults aged 65 years or older
200 mg235 days—
The effect of β-carotene on the mortality of male smokers is modified by smoking and by vitamins C and E: evidence against a uniform effect of nutrient
2020 · α-Tocopherol alone (AT) · Male smokers aged 50–69 years who smoked at least 5 cigarettes per day at entry
50 mg2227 days14,564
Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
1996 · alpha-tocopherol 800 IU daily · Patients with angiographically proven coronary atherosclerosis; age and sex not stated
800 IU510 days546
Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
1996 · alpha-tocopherol 400 IU daily · Patients with angiographically proven coronary atherosclerosis; age and sex not stated
400 IU510 days489
Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial
2000 · vitamin E · Haemodialysis patients aged 40–75 years with pre-existing cardiovascular disease
800 IU519 days97
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis
2010 · vitamin E group · Adults without diabetes with biopsy-confirmed nonalcoholic steatohepatitis
800 IU96 weeks84
The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers
1999 · alpha-tocopherol (AT) · middle-aged male smokers
50 mg——